Product Description
Cluster of differentiation 38 (CD38), also known as ADP-ribosyl cyclase, is a glycoprotein found on the surface of many immune cells (white blood cells), including CD4+, CD8+, B and natural killer cells. It shares several characteristics with ADP-ribosyl cyclase 2 CD157. CD38 is a multifunctional ectoenzyme that catalyzes the synthesis and hydrolysis of cyclic ADP-ribose (cADPR) from NAD+ to ADP-ribose. It also functions in cell adhesion, signal transduction and calcium signaling. CD38 has been used as a prognostic marker in leukemia. It can also be used to identify plasma cells. This enzyme is validated for CD38 Enzymatic activity application.
Product Details
Source: Human
Expression system: HEK293 Cells.
Protein Construction: Val43 ~ Ile300 with a C terminal 6 His tag.
UniProt No: P28907
Alternative Names: ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1, CD38, ADPRC 1, ADPRC1.
Product Specification
N Terminal Sequence Analysis: Val43.
Predicted Molecular Weight: 31.2 kDa (269aa)
SDSPAGE: 43-45 kDa in SDS-PAGE under reducing conditions.
Concentration: 1mg/ml (determined by Bradford assay).
Formulation: Liquid in 50mM MES buffer (pH 6.5) containing 100mM NaCl, 10% glycerol.
Concentration: 1mg/mL.
Purity: > 95% by SDS-PAGE.
Tag: His-Tag.
Biological Activity: Measured by its ability to convert the substrate nicotinamide guanine dinucleotide (NGD+) to cyclic GDP ribose. The specific activity is > 2,500 pmoles/min/μg.
Storage Condition: Store at -20℃ to -80℃. Avoid repeated freezing and thawing cycles.
Endotoxin: < 1.0 EU per μg of the protein as determined by the LAL method.
Protein Sequence: Val43 ~ Ile300.
Applications
Enzymatic Activity, and protein assay by SDS-PAGE
Research use only.
Documents
